Skip to content

Gaming Technology to Engage Adolescent Sickle Cell Patients in Pain Management

PINPOINT: Gaming Technology to Engage Adolescent Sickle Cell Patients in Precision Pain Management

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03291613
Enrollment
13
Registered
2017-09-25
Start date
2017-01-15
Completion date
2017-09-30
Last updated
2019-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sickle Cell Disease

Keywords

Sickle Cell Disease, Adolescence, Pain Assessment, Tablet Application, Pain, mHealth

Brief summary

Sickle cell disease (SCD) is a common genetic disorder characterized by episodes of pain, yet assessments to identify type, intensity, frequency, and phase of pain among SCD adolescents is lacking. Research shows that interactive gaming technology can enhance adolescents' learning, and can be especially effective in delivering health-related messages and tools to improve their self-care. Pinpoint is an interactive gaming tablet app that will be developed with the significant input of clinical experts to assist SCD teens with better identification and self-report of their pain.

Detailed description

Sickle cell disease (SCD) is the most common inherited blood disorder in the U.S. and disproportionately affects African Americans and Hispanics. Approximately, 1,000 U.S. children are born with SCD annually. SCD results from abnormal hemoglobin and causes red blood cells (RBCs) to become misshaped (sickle-shaped). Sickled cells can block the flow of blood in small arteries causing tissue and organ damage and other life-threatening comorbidities. SCD complications can be serious and have a significant impact upon well-being and quality of life. Pain is the hallmark symptom associated with SCD, and is the most common clinical problem seen in children and the number one cause of SCD-related hospital admissions. If left untreated, these painful episodes can result in morbidity and mortality. Accurate assessment of pain specifiers (type, frequency, and intensity of pain) can help with ameliorating pain quickly and effectively. Despite children being accurate self-reporters of their pain, strategies which are effective and engaging to assist with pain identification are lacking. Reducing barriers to collection and promoting the value of accurate SCD pain assessment is a need in pediatric medicine. Pinpoint will be an innovative interactive assessment tool that engages patients while allowing physicians to collect important health data. This project will test the feasibility of applying gamification principles to develop a tablet application (app) for 13-17 year olds with SCD. Specifically, this Phase I SBIR project will (1) develop a Pain Assessment Tool (PAT) to describe and categorize specific types of pain experienced by adolescents with SCD; and (2) create an app (Pinpoint), that will translate the PAT into gamified technology. The goal of Pinpoint is to engage adolescent patients and improve pain specification by developing a game-based pain assessment tool delivered via a tablet app to engage adolescent SCD patients, improve their pain specification self-report, and improve pain management by clinicians. The PAT will be developed using expert guidance from preeminent SCD clinicians. User-centered Design theory will be applied in the development of the app and will be guided by iterative cognitive interviews and focus groups with members of the target population, SCD teens. The project specific aims are to (1) develop the PAT using guidance from an Expert Advisory Board (EAB) of SCD clinicians; (2) conduct a series of cognitive interviews with adolescent SCD patients to guide and refine PAT development; (3) conduct iterative focus groups with adolescent SCD patients to guide and refine user interface design of the Pinpoint app; (4) program a functional Pinpoint prototype; and (5) conduct usability testing of the prototype with 13-17 year old SCD patients to assess functionality, navigation, and satisfaction. This project is innovative and timely. Pinpoint will be the first tablet app to identify and translate specific pain types for SCD into a gamified app using applied gamification principles.

Interventions

Tablet app with pain assessment and communication education, and pain assessment tool.

Sponsors

HPC International, Inc.
CollaboratorINDUSTRY
National Institute on Minority Health and Health Disparities (NIMHD)
CollaboratorNIH
Klein Buendel, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
13 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Phone Interview, Focus Group, and Usability Inclusion Criteria: * Be 13-17 years of age * Be diagnosed with Sickle Cell Disease * Able to read and speak English * Able to assent to participate Phone Interview, Focus Group, and Usability

Exclusion criteria

* Not 13-17 years of age * Not diagnosed with Sickle Cell Disease * Unable to read and speak English * Unable to assent to participate Healthcare Provider Interview Inclusion Criteria: * Be a healthcare provider to teens with sickle cell disease * Be 18 years of age or older * Able to read and speak English * Able to consent to participate Healthcare Provider Interview

Design outcomes

Primary

MeasureTime frameDescription
System Usability QuestionnaireAfter 1-hour usability sessionTen likert-type questions assessing user-friendliness of technology. Each question has five answer options that range from Strongly Agree to Strongly Disagree. Scores range from 0-100. A score of 68 or above is considered above average. All scores averaged.

Countries

United States

Participant flow

Participants by arm

ArmCount
Pinpoint App Usability Testing
Participants used the Pinpoint tablet app for one hour.
12
Total12

Baseline characteristics

CharacteristicPinpoint App Usability Testing
Age, Continuous14.58 years
STANDARD_DEVIATION 1
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
11 Participants
Race (NIH/OMB)
More than one race
1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
0 Participants
Region of Enrollment
United States
12 participants
Sex: Female, Male
Female
5 Participants
Sex: Female, Male
Male
7 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 12
other
Total, other adverse events
0 / 12
serious
Total, serious adverse events
0 / 12

Outcome results

Primary

System Usability Questionnaire

Ten likert-type questions assessing user-friendliness of technology. Each question has five answer options that range from Strongly Agree to Strongly Disagree. Scores range from 0-100. A score of 68 or above is considered above average. All scores averaged.

Time frame: After 1-hour usability session

ArmMeasureValue (MEAN)Dispersion
Pinpoint AppSystem Usability Questionnaire86.67 units on a scaleStandard Deviation 11.56

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026